Abstract
Purpose
Asymptomatic pharyngeal gonorrhoea could play an important role in transmission and should be screened for in persons at risk. We investigated the sensitivity of oral gargle samples to detect N. gonorrhoea and describe the frequency of infection by anatomical site.
Methods
From June 2021 to July 2022 persons diagnosed with gonorrhoea in the STI/HIV department were asked to provide self-collected specimens for single-site testing by NAAT from throat (by gargling and swabbing), anorectum, and first-void urine.
Results
104 episodes of gonorrhoea were analysed in 88 individuals. The median age was 33 years, 85 persons (96.5%) were male. The pharynx was the most common site of infection (71 cases, 68.2%); in 26 persons (25.0%) it was the only site of infection. Anorectal infection was detected in 65 cases (62.5%) and urogenital infection in 25 cases (24.0%). In 46 cases (44.2%) infection was detected in more than one anatomical site. Gargling was less sensitive than throat swabbing to detect pharyngeal infection (85.9% versus 97.2%, p = .038), but was preferred by patients. Only 4 of 71 pharyngeal infections (5.6%) were symptomatic; anorectal and urogenital infections were symptomatic in 12.3% and 76.0% of cases, respectively. Culture recovery of N.gonorrhoeae was only possible in 15.8% of throat swabs, but was successful in 61.9% of anorectal and 84.2% of urogenital samples.
Conclusions
Asymptomatic pharyngeal gonorrhoea is common. Gargle samples should be used only as alternative specimens with inferior sensitivity compared to throat swab samples.
Similar content being viewed by others
Data availability
Data is provided within the manuscript.
References
Centers for Disease Control and Prevention (2019) Sexually Transmitted Disease Surveillance, 2018. Atlanta, GA: US Department of Health and Human Services. https://www.cdc.gov/std/stats18/default.htm
European Centre for Disease Prevention and Control (2020) Gonorrhoea. In: ECDC. Annual epidemiological report for 2018. Stockholm: ECDC
Llata E, Braxton J, Asbel L, et al. New human immunodeficiency virus diagnoses among men who have sex with men attending sexually transmitted disease clinics, std surveillance network, january 2010 to june 2013. Sex Transm Dis. 2018;45:577.
Chang S-X, Chen K-K, Liu X-T, et al. Cross-sectional study of asymptomatic Neisseria gonorrhoeae and Chlamydia trachomatis infections in sexually transmitted disease related clinics in Shenzhen, China. PLoS ONE. 2020;15:e0234261.
Donovan LC, Fairley CK, Aung ET, et al. The presence or absence of symptoms among cases of urethral gonorrhoea occurring in a cohort of men taking human immunodeficiency virus pre-exposure prophylaxis in the PrEPX study. Open Forum Infect Dis. 2021;8:ofab263.
Nadal-Baron P, Salmeron P, Garcia JN, et al. Neisseria gonorrhoeae culture growth rates from asymptomatic individuals with a positive nucleic acid amplification test. Lett Appl Microbiol. 2022;75:1215–24.
Chan PA, Robinette A, Montgomery M, et al. Extragenital infections caused by Chlamydia trachomatis und Neisseria gonorrhoeae: a review of the literature. Infect Dis Obstet Gynecol. 2016;2016:5758387.
Ross JDC, Brittain C, Cole M, et al. Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomized non-inferiority trial. Lancet. 2019;393:2511–20.
Deguchi T, Yasuda M, Ito S. Management of pharyngeal gonorrhea is crucial to prevent the emergence and spread of antibiotic-resistant Neisseria gonorrhoeae. Antimicrob Agents Chemother. 2012;56:4039.
Adamson PC, Klausner JD. The staying power of pharyngeal gonorrhea: implications for public health and antimicrobial resistance. Clin Infect Dis. 2021;73:583–5.
Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70:1.
Giuliani M, Gheit T, Rollo F, et al. Predictors of oral infection by mucosal and cutaneous human papillomaviruses in HIV-infected and uninfected men who have sex with men of the OHMAR study. J Clin Med. 2021;10:2804.
Cho H, Kishikawa T, Tokita Y, et al. Prevalence of human papillomavirus in oral gargles and tonsillar washings. Oral Oncol. 2020;105:104669.
De Santana Sarmento DJ, Tozetto-Mendoza TR, Masami Sumita L, et al. Oral shedding of human herpesviruses in renal transplant recipients. Clin Oral Invest. 2018;22:885–91.
Kirby A, Dove W, Ashton L, Hopkins M, Cunliffe NA. Detection of norovirus in mouthwash samples from patients with acute gastroenteritis. J Clin Virol. 2010;48:285–7.
Bennett S, Davidson RS, Gunson RN. Comparison of gargle samples and throat swab samples for the detection of respiratory pathogens. J Virol Methods. 2017;248:83–6.
Willeit P, Krause R, Lamprecht B, et al. Prevalence of RT-qPCR-detected SARS-CoV-2 infection at schools: first results from the Austrian school-SARS-CoV-2 prospective cohort study. Lancet Reg Health Eur. 2021;5:100086.
Kheiroddin P, Schöberl P, Althammer M, et al. Results of the WICOVIR gargle pool PCR testing in German schools based on the first 100000 tests. Front Pediatr. 2021;9:721518.
Papp JR, Ahrens K, Phillips C, et al. The use and performance of oral-throat rinses to detect pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections. Diagn Microbiol Infect Dis. 2007;59:259–64.
Kumamoto Y, Matsumoto T, Fujisawa M, Arakawa S. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urogenital and oral specimens using the COBAS 4800, Aptima Combo 2 TMA, and Probetec et SDA Assays. Eur J Microbiol Immunol. 2012;2:121–7.
Ando N, Mizushima D, Watanabe K, et al. Modified self-obtained pooled sampling to screen for Chlamydia trachomatis and Neisseria gonorrhoeae infections in men who have sex with men. Sex Transm Infect. 2021;97:324–8.
Takahashi S, Kurimura Y, Hashimoto J, et al. Pharyngeal Neisseria gonorrhoeae detection in oral-throat wash specimens of male patients with urethritis. J Infect Chemother. 2008;14:442–4.
Kinshella MW, Tilley P, Al-Rawahi GN, et al. Evaluation of observed and unobserved self-collection of saline gargle samples for the detection of SARS-CoV-2 in outpatients. Diagn Microbiol Infect Dis. 2022;102:115566.
Laumen JGE, Abdellati S, Van Dijck C, et al. A novel method to assess antimicrobial susceptibility in commensal oropharyngeal Neisseria - a pilot study. Antibiotics. 2022;11:100.
Wayal S, Llewellyn C, Smith H, et al. Self-sampling for oropharyngeal and rectal specimens to screen for sexually transmitted infection: acceptability among men who have sex with men. Sex Transm Infect. 2009;85:60–4.
Tabesh M, Fairley CK, Hocking JS, et al. Comparison of patterns of chlamydia and gonorrhoea at the oropharynx, anorectum and urethra among men who have sex with men. Sex Transm Infect. 2022;98:11–6.
Man OM, Ramos WE, Vavala G, et al. Optimizing screening for anorectal, pharyngeal, and urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infections in at-risk adolescents and young adults in New Orleans, Louisiana and Los Angeles, California. U S Clin Infect Dis. 2021;73:e3201–9.
McLaughlin SE, Golden MR, Soge OO, et al. Pharyngeal gonorrhoea in heterosexual male and female sex partners of persons with gonorrhoea. Sex Transm Dis. 2023;50:203–8.
Morris SR, Klausner JD, Buchbinder SP, et al. Prevalence and incidence of pharyngeal gonorrhea in a longitudinal sample of men who have sex with men: the EXPLORE study. Clin Infect Dis. 2006;43:1284–9.
Barbee LA, Soge OO, Khosropour CM, et al. The duration of pharyngeal gonorrhea: a natural history study. Clin Infect Dis. 2021;73:575–82.
Chow EP, Camilleri S, Ward C, et al. Duration of gonorrhoea and chlamydia infection at the pharynx and rectum among men who have sex with men: a systematic review. Sex Health. 2016;13:199–204.
Tabrizi SN, Unemo M, Limnios AE, et al. Evaluation of six commercial nucleic acid amplification tests for the detection of Neisseria gonorrhoeae and other Neisseria species. J Clin Microbiol. 2011;49:3610–5.
Nash EE, Pham CD, Raphael B, et al. Impact of anatomic site, specimen collection timing, and patient symptom status on Neisseria gonorrhoeae culture recovery. Sex Transm Dis. 2021;48:S151–6.
Barbee LA, Soge OO, Khosropour CM, et al. Time to clearance of Neisseria gonorrhoeae RNA at the pharynx following treatment. J Clin Microbiol. 2022;60:e0039922.
Teker B, de Vries H, Heijman T, et al. Spontaneous clearance of asymptomatic anogenital and pharyngeal Neisseria gonorrhoeae: a secondary analysis from the NABOGO trial. Sex Transm Infect. 2023;99:219–25.
Vyth R, Leval A, Eriksson B, et al. Gonorrhoea diagnostic and treatment uncertainties: risk factors for culture negative confirmation after positive nucleic acid amplification tests. PLoS ONE. 2016;11:e0155017.
Funding
No funding was received for conducting this study.
Author information
Authors and Affiliations
Contributions
Study concept: MK, MS. Clinical data acquisition: MK, MG, MW, EM. Molecular diagnostics: WTB. Cultures: MAG. Manuscript preparation: MK,MS. All authors have read and approved the definitive version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no competing interests to declare that are relevant to the content of this article.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kitchen, M., Borena, W.T., Gisinger, M. et al. Pharyngeal gonococcal infection and the sensitivity of oral gargle samples in comparison to self-collected throat swabs for the detection of N. gonorrhoeae in persons in Tyrol, Austria. Infection (2024). https://doi.org/10.1007/s15010-024-02359-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s15010-024-02359-x